These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 21948321

  • 1. Sustained-release delivery of octreotide from biodegradable polymeric microspheres.
    Rhee YS, Sohn M, Woo BH, Thanoo BC, DeLuca PP, Mansour HM.
    AAPS PharmSciTech; 2011 Dec; 12(4):1293-301. PubMed ID: 21948321
    [Abstract] [Full Text] [Related]

  • 2. Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation method.
    Beig A, Ackermann R, Wang Y, Schutzman R, Schwendeman SP.
    Int J Pharm; 2022 Aug 25; 624():121842. PubMed ID: 35609832
    [Abstract] [Full Text] [Related]

  • 3. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
    Ghassemi AH, van Steenbergen MJ, Barendregt A, Talsma H, Kok RJ, van Nostrum CF, Crommelin DJ, Hennink WE.
    Pharm Res; 2012 Jan 25; 29(1):110-20. PubMed ID: 21744173
    [Abstract] [Full Text] [Related]

  • 4. Modeling the kinetics of release of octreotide from long-acting formulations injected intramuscularly in rabbits.
    Comets E, Mentré F, Kawai R, Nimmerfall F, Marbach P, Vonderscher J.
    J Pharm Sci; 2000 Sep 25; 89(9):1123-33. PubMed ID: 10944377
    [Abstract] [Full Text] [Related]

  • 5. Development and characterization of composition-equivalent formulations to the Sandostatin LAR® by the solvent evaporation method.
    Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, Wang Y, Schwendeman SP.
    Drug Deliv Transl Res; 2022 Mar 25; 12(3):695-707. PubMed ID: 34215997
    [Abstract] [Full Text] [Related]

  • 6. Pore change during degradation of octreotide acetate-loaded PLGA microspheres: The effect of polymer blends.
    Wang T, Xue P, Wang A, Yin M, Han J, Tang S, Liang R.
    Eur J Pharm Sci; 2019 Oct 01; 138():104990. PubMed ID: 31302216
    [Abstract] [Full Text] [Related]

  • 7. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres.
    Beig A, Feng L, Walker J, Ackermann R, Hong JKY, Li T, Wang Y, Qin B, Schwendeman SP.
    Mol Pharm; 2020 Nov 02; 17(11):4141-4151. PubMed ID: 32876463
    [Abstract] [Full Text] [Related]

  • 8. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S, Faraj J, DeLuca P.
    Eur J Pharm Biopharm; 2013 Nov 02; 85(3 Pt A):631-9. PubMed ID: 23892159
    [Abstract] [Full Text] [Related]

  • 9. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.
    Wang J, Wang BM, Schwendeman SP.
    Biomaterials; 2004 May 02; 25(10):1919-27. PubMed ID: 14738856
    [Abstract] [Full Text] [Related]

  • 10. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloyl-hydroxyethyl starch)-PLGA composite microspheres.
    Jiang G, Qiu W, DeLuca PP.
    Pharm Res; 2003 Mar 02; 20(3):452-9. PubMed ID: 12669968
    [Abstract] [Full Text] [Related]

  • 11. Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stability.
    Ahmed TA, Ibrahim HM, Samy AM, Kaseem A, Nutan MT, Hussain MD.
    AAPS PharmSciTech; 2014 Jun 02; 15(3):772-80. PubMed ID: 24648158
    [Abstract] [Full Text] [Related]

  • 12. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
    Desai KG, Mallery SR, Schwendeman SP.
    Eur J Pharm Biopharm; 2008 Sep 02; 70(1):187-98. PubMed ID: 18472254
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres.
    Wang J, Wang BM, Schwendeman SP.
    J Control Release; 2002 Aug 21; 82(2-3):289-307. PubMed ID: 12175744
    [Abstract] [Full Text] [Related]

  • 14. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
    Sinha VR, Trehan A.
    Drug Deliv; 2005 Aug 21; 12(3):133-9. PubMed ID: 16025842
    [Abstract] [Full Text] [Related]

  • 15. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.
    Murty SB, Goodman J, Thanoo BC, DeLuca PP.
    AAPS PharmSciTech; 2003 Oct 13; 4(4):E50. PubMed ID: 15198545
    [Abstract] [Full Text] [Related]

  • 16. Preparation of bleomycin A2-PLGA microspheres and related in vitro and in vivo studies.
    Zhang H, Gao Y, Lv W, Jiao C, Duan M, Liu H, Han B.
    J Pharm Sci; 2011 Jul 13; 100(7):2790-800. PubMed ID: 21344412
    [Abstract] [Full Text] [Related]

  • 17. Goserelin Acetate Loaded Poloxamer Hydrogel in PLGA Microspheres: Core-Shell Di-Depot Intramuscular Sustained Release Delivery System.
    Qi P, Bu R, Zhang H, Yin J, Chen J, Zhang A, Gou J, Yin T, Zhang Y, He H, Wang P, Tang X, Wang Y.
    Mol Pharm; 2019 Aug 05; 16(8):3502-3513. PubMed ID: 31251642
    [Abstract] [Full Text] [Related]

  • 18. Design of Controlled Release PLGA Microspheres for Hydrophobic Fenretinide.
    Zhang Y, Wischke C, Mittal S, Mitra A, Schwendeman SP.
    Mol Pharm; 2016 Aug 01; 13(8):2622-30. PubMed ID: 27144450
    [Abstract] [Full Text] [Related]

  • 19. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release.
    Liang D, Frank S, Schwendeman SP.
    Drug Deliv Transl Res; 2024 Mar 01; 14(3):696-704. PubMed ID: 38038895
    [Abstract] [Full Text] [Related]

  • 20. Preparation of sustained release microparticles with improved initial release property.
    Jung GY, Na YE, Park MS, Park CS, Myung PK.
    Arch Pharm Res; 2009 Mar 01; 32(3):359-65. PubMed ID: 19387579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.